The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.

[1]  C. Löwik,et al.  Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. , 1992, The Journal of endocrinology.

[2]  C. Löwik,et al.  Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix. , 1991, Endocrinology.

[3]  J. Verheijen,et al.  Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells. , 1991, Bone and mineral.

[4]  D. Rijken,et al.  Binding of tissue-type plasminogen activator by the mannose receptor. , 1991, The Journal of biological chemistry.

[5]  S. Marks,et al.  Skeletal development and formation of osteoclast-like cells from in situ progenitors in fetal mouse metatarsals cultured in chemically defined medium. , 1991, Bone and mineral.

[6]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[7]  K. Hajjar,et al.  Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. , 1990, The Journal of biological chemistry.

[8]  R. Ziegler,et al.  Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors. , 1990, Endocrinology.

[9]  J. Heersche,et al.  Expression of calcitonin receptors during osteoclast differentiation in mouse metatarsals , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  L. Aarden,et al.  Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. , 1989, Biochemical and biophysical research communications.

[11]  N. Seeds,et al.  Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons , 1989, The Journal of cell biology.

[12]  M. Laiho,et al.  Growth factors in the regulation of pericellular proteolysis: a review. , 1989, Cancer research.

[13]  K. Marotti,et al.  Construction of a tissue plasminogen activator gene having unique restriction sites to facilitate domain manipulation: a model for the analysis of multi-domain proteins. , 1989, Protein engineering.

[14]  V. Shen,et al.  Bone‐resorbing agents promote and interferon‐γ inhibits bone cell collagenase production , 1988 .

[15]  G. Mundy,et al.  Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. , 1988, The Journal of clinical investigation.

[16]  J. Quigley,et al.  Protease receptors on cell surfaces: new mechanistic formulas applied to an old problem. , 1988, Journal of the National Cancer Institute.

[17]  J. Delaisse,et al.  Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. , 1988, Endocrinology.

[18]  F. Blasi.  Surface Receptors for Urokinase Plasminogen Activator , 1988 .

[19]  N. Krieger.  Rising incidence of breast cancer. , 1988, Journal of the National Cancer Institute.

[20]  S. Teitelbaum,et al.  Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells. , 1987, Endocrinology.

[21]  G. Mundy.  The hypercalcemia of malignancy. , 1987, Kidney international.

[22]  R. Derynck,et al.  Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. , 1986, The Journal of clinical investigation.

[23]  T. Martin,et al.  Cyclic AMP-dependent and -independent effects on tissue-type plasminogen activator activity in osteogenic sarcoma cells; evidence from phosphodiesterase inhibition and parathyroid hormone antagonists. , 1986, Biochimica et biophysica acta.

[24]  G. Dini,et al.  The Mr 17500 region of the A chain of urokinase is required for interaction with a specific receptor in A431 cells. , 1986, Biochimica et biophysica acta.

[25]  Bijvoet Ol,et al.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. , 1986 .

[26]  J. Delaisse,et al.  A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. , 1985, Biochemical and biophysical research communications.

[27]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[28]  R. Derynck,et al.  Human transforming growth factor-alpha stimulates bone resorption in vitro. , 1985, The Journal of clinical investigation.

[29]  T. Martin,et al.  Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts. , 1985, Endocrinology.

[30]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[31]  J. Reynolds,et al.  Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. , 1984, Biochimica et biophysica acta.

[32]  F. Elgh,et al.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Thomson,et al.  Effect of substrate composition on bone resorption by rabbit osteoclasts. , 1984, Journal of cell science.

[34]  D. Collen,et al.  Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones. , 1984, Thrombosis research.

[35]  J. Hock,et al.  DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones. , 1983, The Journal of clinical investigation.

[36]  S. Sung,et al.  Yeast Mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages , 1983, The Journal of cell biology.

[37]  S. Teitelbaum,et al.  Recruitment of osteoclast precursors by purified bone matrix constituents , 1982, The Journal of cell biology.

[38]  L. Liotta,et al.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. , 1981, Cancer research.

[39]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[40]  E. Canalis,et al.  Direct stimulation of bone resorption by epidermal growth factor. , 1980, Endocrinology.

[41]  H. Penefsky.  Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. , 1977, The Journal of biological chemistry.

[42]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.

[43]  G. Vaes.  The release of collagenase as an inactive proenzyme by bone explants in culture. , 1972, The Biochemical journal.

[44]  L. Raisz.  BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. , 1965, The Journal of clinical investigation.